{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:11:07Z","timestamp":1791389467716,"version":"4.3.3"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"DOI":"10.1186\/s12954-026-01448-4","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T07:02:13Z","timestamp":1776409333000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Foreword: the enhanced games\u2014human enhancement, risk, and harm reduction in a post-doping era"],"prefix":"10.1186","volume":"23","author":[{"given":"Imran","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke","family":"Cox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle T.","family":"Ganson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Piatkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,17]]},"reference":[{"key":"1448_CR1","doi-asserted-by":"crossref","unstructured":"Gibbs N, Piatkowski T, Turnock L. Down the greasy slope: the fatal contradictions of anti-doping. Sport Ethics Philos. 2024:1\u201320.","DOI":"10.1080\/17511321.2024.2432949"},{"issue":"1","key":"1448_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1177\/13634593241306569","volume":"30","author":"T Piatkowski","year":"2026","unstructured":"Piatkowski T, Turnock L, Gibbs N, Duff C. The IPEDs assemblage: Tracing the entanglements of biomedicine, technology, enhancement and anti-doping policies in sport and society. Health. 2026;30(1):3\u201321.","journal-title":"Health"},{"issue":"3","key":"1448_CR3","doi-asserted-by":"publisher","first-page":"100341","DOI":"10.1016\/j.peh.2025.100341","volume":"13","author":"M Chandler","year":"2025","unstructured":"Chandler M, Boardley I. Harm reduction in the Enhanced Games: Can performance enhancing drugs be \u2018safe\u2019? Perform Enhancement Health. 2025;13(3):100341.","journal-title":"Perform Enhancement Health"},{"issue":"3","key":"1448_CR4","doi-asserted-by":"publisher","first-page":"100285","DOI":"10.1016\/j.peh.2024.100285","volume":"12","author":"A Richardson","year":"2024","unstructured":"Richardson A. The enhanced games or enhancing harm? Perform Enhancement Health. 2024;12(3):100285.","journal-title":"Perform Enhancement Health"},{"issue":"4","key":"1448_CR5","doi-asserted-by":"publisher","first-page":"100295","DOI":"10.1016\/j.peh.2024.100295","volume":"12","author":"LA Turnock","year":"2024","unstructured":"Turnock LA. The Enhanced Games: Prohibition, harm reduction & the future of sport. Perform Enhancement Health. 2024;12(4):100295.","journal-title":"Perform Enhancement Health"},{"issue":"4","key":"1448_CR6","doi-asserted-by":"publisher","first-page":"100294","DOI":"10.1016\/j.peh.2024.100294","volume":"12","author":"A Henning","year":"2024","unstructured":"Henning A. Risk, harm, and the enhanced games: Whose job is harm reduction? Perform Enhancement Health. 2024;12(4):100294.","journal-title":"Perform Enhancement Health"},{"issue":"1","key":"1448_CR7","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s40592-022-00170-8","volume":"41","author":"A Walsh","year":"2023","unstructured":"Walsh A, van de Ven K. Human enhancement drugs and Armed Forces: an overview of some key ethical considerations of creating \u2018Super-Soldiers\u2019. Monash Bioeth Rev. 2023;41(1):22\u201336.","journal-title":"Monash Bioeth Rev"},{"issue":"3\u20134","key":"1448_CR8","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.peh.2019.03.001","volume":"6","author":"KJ Mulrooney","year":"2019","unstructured":"Mulrooney KJ, van de Ven K, McVeigh J, Collins R. Steroid madness-has the dark side of anabolic-androgenic steroids (AAS) been over-stated? Perform Enhancement Health. 2019;6(3\u20134):98\u2013102.","journal-title":"Perform Enhancement Health"},{"issue":"6","key":"1448_CR9","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1177\/036354658401200613","volume":"12","author":"HA Haupt","year":"1984","unstructured":"Haupt HA, Rovere GD. Anabolic steroids: a review of the literature. Am J Sports Med. 1984;12(6):469\u201384.","journal-title":"Am J Sports Med"},{"key":"1448_CR10","doi-asserted-by":"crossref","unstructured":"Gibbs N. # Sponseredathlete: the marketing of image and performance enhancing drugs on Facebook and Instagram. Trends Organized Crime. 2023:1\u201340.","DOI":"10.1007\/s12117-023-09491-4"},{"issue":"1","key":"1448_CR11","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1177\/26338076231209044","volume":"57","author":"T Piatkowski","year":"2024","unstructured":"Piatkowski T, Gibbs N, Dunn M. Beyond the law: exploring the impact of criminalising anabolic\u2013androgenic steroid use on help-seeking and health outcomes in Australia. J Criminol. 2024;57(1):62\u201382.","journal-title":"J Criminol"},{"issue":"2","key":"1448_CR12","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1080\/09595239800187011","volume":"17","author":"S Lenton","year":"1998","unstructured":"Lenton S, Single E. The definition of harm reduction. Drug Alcohol Rev. 1998;17(2):213\u20139.","journal-title":"Drug Alcohol Rev"},{"issue":"6","key":"1448_CR13","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1080\/09595230600944529","volume":"25","author":"A Ritter","year":"2006","unstructured":"Ritter A, Cameron J. A review of the efficacy and effectiveness of harm reduction strategies for alcohol, tobacco and illicit drugs. Drug Alcohol Rev. 2006;25(6):611\u201324.","journal-title":"Drug Alcohol Rev"},{"issue":"7","key":"1448_CR14","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1111\/add.70009","volume":"120","author":"T Piatkowski","year":"2025","unstructured":"Piatkowski T, Coomber R, Francis C, Kill E, Davey G, Cresswell S, et al. The world\u2019s first anabolic-androgenic steroid testing trial: A two-phase pilot combining chemical analysis, results dissemination and community feedback. Addiction. 2025;120(7):1366\u201377.","journal-title":"Addiction"},{"key":"1448_CR15","doi-asserted-by":"publisher","first-page":"1490651","DOI":"10.3389\/fspor.2024.1490651","volume":"6","author":"D Ekdahl","year":"2024","unstructured":"Ekdahl D, Krieger J. The enhanced games: a timely injection for the international olympic committee. Front Sports Act Living. 2024;6:1490651.","journal-title":"Front Sports Act Living"},{"issue":"2","key":"1448_CR16","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1080\/14461242.2024.2388528","volume":"34","author":"T Piatkowski","year":"2025","unstructured":"Piatkowski T, Cox L, Collins R. The ethics of enhancement among image and performance enhancing drug coaches. Health Sociol Rev. 2025;34(2):152\u201366.","journal-title":"Health Sociol Rev"},{"issue":"1","key":"1448_CR17","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1186\/s12954-025-01321-w","volume":"22","author":"L Cox","year":"2025","unstructured":"Cox L, Khan I. Bigger than sport: the enhanced games and the commodification of telehealth, testosterone, and dependency. Harm Reduct J. 2025;22(1):180.","journal-title":"Harm Reduct J"},{"issue":"4","key":"1448_CR18","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1080\/17461391.2011.566374","volume":"12","author":"S Loland","year":"2012","unstructured":"Loland S, Hoppeler H. Justifying anti-doping: The fair opportunity principle and the biology of performance enhancement. Eur J Sport Sci. 2012;12(4):347\u201353.","journal-title":"Eur J Sport Sci"},{"issue":"4","key":"1448_CR19","doi-asserted-by":"publisher","first-page":"100296","DOI":"10.1016\/j.peh.2024.100296","volume":"12","author":"LTJ Cox","year":"2024","unstructured":"Cox LTJ, Piatkowski T. Enhancing autonomy through the \u2018Enhanced Games\u2019. Perform Enhancement Health. 2024;12(4):100296.","journal-title":"Perform Enhancement Health"},{"issue":"3","key":"1448_CR20","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.drugpo.2008.10.003","volume":"20","author":"T Rhodes","year":"2009","unstructured":"Rhodes T. Risk environments and drug harms: a social science for harm reduction approach. Int J Drug Policy. 2009;20(3):193\u2013201.","journal-title":"Int J Drug Policy"}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-026-01448-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12954-026-01448-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-026-01448-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T07:02:31Z","timestamp":1776409351000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12954-026-01448-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,17]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1448"],"URL":"https:\/\/doi.org\/10.1186\/s12954-026-01448-4","relation":{},"ISSN":["1477-7517"],"issn-type":[{"value":"1477-7517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,17]]},"assertion":[{"value":"17 April 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"IK has undertaken consulting activities with the proposed Enhanced Games and has received funding related to a range of advisory and engagement roles, including providing guidance and attending events related to athlete safety and enhancement policies. IK, LC, and TP are members of the Performance Enhancement Task Force, an independent advisory group convened to provide external expertise on ethics, athlete safety, health monitoring, and harm reduction; they have received funding for contributions to athlete safety and wellbeing materials. KG has received no funding or financial support related to the Enhanced Games. None of the authors hold governance or operational roles within the Enhanced Games organisation, and none hold ownership, equity, or financial interests in the Games or affiliated commercial entities. Two authors (IK & TP) also acknowledge lived(-ing) experience of enhancement drug use across sport and non-sport settings. Both authors have longstanding professional and community connections with people who use enhancement drugs, particularly in Australia, Thailand, New Zealand, and the United Kingdom, through ongoing research and harm reduction work. LC and KG are recognised by the co-authors as established allies in enhancement drug-related research and practice, with a demonstrated commitment to ethical engagement, participant safety, and harm reduction principles. All authors affirm that the views expressed in this editorial and the associated Collection are their own and were developed independently of the Enhanced Games organisation. Editorial decisions and peer review for this Collection are managed in accordance with the Harm Reduction Journal\u2019s standard procedures, with appropriate safeguards to ensure independence and academic integrity.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"80"}}